XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - UNAUDITED - USD ($)
$ in Thousands
Common Stock
Additional Paid-in-Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Beginning balance at Dec. 31, 2020 $ 45 $ 433,941 $ 247,638 $ 14,087 $ 695,711
Beginning balance (in shares) at Dec. 31, 2020 44,667,650        
Net income     85,635   85,635
Other comprehensive loss       (5,320) (5,320)
Stock based compensation   2,202     2,202
Cash dividend     (12,089)   (12,089)
Exercise of options   1,880     1,880
Exercise of options (in shares) 211,203        
Stock grants - vesting of restricted stock units (in shares) 117,223        
Repurchase of shares from restricted shares vesting   (1,188)     (1,188)
Repurchase of shares from restricted shares vesting (in shares) (40,937)        
Ending balance at Sep. 30, 2021 $ 45 436,835 321,184 8,767 766,831
Ending balance (in shares) at Sep. 30, 2021 44,955,139        
Beginning balance at Jun. 30, 2021 $ 45 435,201 287,997 10,775 734,018
Beginning balance (in shares) at Jun. 30, 2021 44,819,743        
Net income     37,226   37,226
Other comprehensive loss       (2,008) (2,008)
Stock based compensation   573     573
Cash dividend     (4,039)   (4,039)
Exercise of options   1,061     1,061
Exercise of options (in shares) 135,396        
Ending balance at Sep. 30, 2021 $ 45 436,835 321,184 8,767 766,831
Ending balance (in shares) at Sep. 30, 2021 44,955,139        
Beginning balance at Dec. 31, 2021 $ 56 720,744 340,976 2,275 1,064,051
Beginning balance (in shares) at Dec. 31, 2021 56,432,070        
Net income     93,158   93,158
Other comprehensive loss       (15,828) (15,828)
Stock based compensation   2,770     2,770
Cash dividend     (18,627)   (18,627)
Exercise of options   18     18
Exercise of options (in shares) 2,000        
Stock grants - vesting of restricted stock units (in shares) 134,374        
Repurchase of shares from restricted shares vesting   (1,120)     (1,120)
Repurchase of shares from restricted shares vesting (in shares) (43,190)        
Stock repurchases   (2,457)     (2,457)
Stock repurchases (Shares) (137,583)        
Ending balance at Sep. 30, 2022 $ 56 719,955 415,507 (13,553) 1,121,965
Ending balance (in shares) at Sep. 30, 2022 56,387,671        
Beginning balance at Jun. 30, 2022 $ 56 719,222 392,704 (9,073) 1,102,909
Beginning balance (in shares) at Jun. 30, 2022 56,386,914        
Net income     29,006   29,006
Other comprehensive loss       (4,480) (4,480)
Stock based compensation   733     733
Cash dividend     (6,203)   (6,203)
Stock grants - vesting of restricted stock units (in shares) 1,000        
Repurchase of shares from restricted shares vesting (in shares) (243)        
Ending balance at Sep. 30, 2022 $ 56 $ 719,955 $ 415,507 $ (13,553) $ 1,121,965
Ending balance (in shares) at Sep. 30, 2022 56,387,671